Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

NCT01376167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

851

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Vivax

Interventions

DRUG: Chloroquine 600mg
DRUG: Chloroquine 300mg
DRUG: Tafenoquine 50mg
DRUG: Tafenoquine 100mg
DRUG: Tafenoquine 300mg
DRUG: Tafenoquine 600mg
DRUG: Primaquine 15mg
DRUG: Chloroquine 600mg (Part 2 )
DRUG: Chloroquine 300mg (Part 2 )
DRUG: Tafenoquine 300mg (Part 2)
DRUG: Primaquine 15mg (Part2 )

Sponsor

GlaxoSmithKline

Collaborators

[object Object]